• Metoprolol Tartrate: β1 Research Workflow

  2026-09-16

  Metoprolol Tartrate provides a selective β1-adrenergic blocking agent for separating cardiac receptor effects from broader β-adrenergic signaling. This guide translates cardiovascular and hematopoietic findings into practical assay workflows, comparison strategies, and troubleshooting decisions.

• Cell Cycle Assay Kit for Flow Cytometry

  2026-09-15

  Use DNA-content profiling to distinguish G0/G1, S, and G2/M redistribution from treatment-associated sub-G1 loss. This workflow combines practical PI/RNase A staining with mechanistic interpretation for cancer research cell proliferation and apoptosis studies.

• a-MSH, Amide for Melanogenesis Workflows

  2026-09-15

  Use a-MSH, amide as a controlled melanocortin challenge to separate genuine melanin synthesis modulation from toxicity, formulation artifacts, and nonspecific stress. This workflow connects pigmentation regulation research with receptor pharmacology and carefully bounded anti-inflammatory peptide research.

• Ruxolitinib Phosphate: JAK1/2 Research Workflows

  2026-09-14

  Build cleaner JAK/STAT experiments with a selective JAK1/JAK2 inhibitor suited to cytokine signaling, inflammatory models, and mechanistic oncology studies. This workflow translates the ATC apoptosis–pyroptosis findings into practical target-engagement, mitochondrial, and cell-death assays.

• G4–STAT1 Disruption Enhances Olaparib Activity

  2026-09-14

  The reference study identifies a promoter-level mechanism in which a BLM G-quadruplex recruits phosphorylated STAT1 to promote BLM expression. Natural alkaloids that disrupt this interaction suppress DNA repair capacity and synergize with olaparib in colon cancer cells, providing a mechanistic rationale for combining G4-directed compounds with PARP inhibition.

• MDV3100: Turning AR Heterogeneity Into Strategy

  2026-09-13

  MDV3100 (Enzalutamide) is more than a potent androgen receptor antagonist: it is a mechanistic probe for understanding why prostate cancer models diverge under androgen deprivation and AR-directed treatment. This article connects AR localization and expression heterogeneity to experimental design, resistance biology, and translational decision-making.

• Mechanical Stress, Cytoskeleton, and Autophagy

  2026-09-12

  The reference study shows that compression-induced autophagy depends strongly on cytoskeletal organization, with microfilaments acting as core structural mediators and microtubules contributing an auxiliary role. Its combined use of cytoskeletal perturbation, fluorescence imaging, and western blotting provides a practical framework for studying how mechanical inputs become autophagy signals.

• Sodium Orthovanadate: The Signal Preservation Edge

  2026-09-12

  Sodium Orthovanate (Na3VO4) is more than a routine phosphatase inhibitor. This thought-leadership guide explains how phosphorylation state preservation can strengthen insulin-signaling research, improve assay interpretation, and support more disciplined translational decisions.

• Anti-Inflammatory Airway Stent Targets TISR

  2026-09-11

  Zhao et al. developed PAGL, an electrospun airway stent that combines anlotinib hydrochloride with silver nanoparticles to address inflammation, infection, angiogenesis, and fibroblast activation in tracheal in-stent restenosis. Results from cell studies, a New Zealand rabbit model, and RNA sequencing support a multi-mechanism strategy, while species differences and long-term safety remain important translational questions.

• G007-LK: A Mechanism-First Tankyrase Guide

  2026-09-11

  G007-LK is a selective tankyrase 1/2 inhibitor for resolving how Wnt/β-catenin and Hippo pathway outputs change across cancer models. This mechanism-first guide connects biochemical potency with assay design, β-catenin degradation induction, and interpretation of colorectal and hepatocellular carcinoma data.

• Chlorin e6: From ROS to Smarter PDT Assays

  2026-09-10

  Chlorin e6 is a versatile Ce6 photosensitizer for mechanistic, anticancer, and antibacterial photodynamic therapy research. This article explains how its photochemistry, formulation, illumination, and biological readouts can be aligned to build more reproducible PDT assays.

• Acetylcholine Chloride: From Signal to Causality

  2026-09-10

  Acetylcholine Chloride is a precise tool for dissecting acetylcholine neurotransmitter signaling across gut, vagal, and neuronal models. This article translates recent gut-brain epilepsy findings into a causal assay framework that distinguishes receptor activation from microbiota-driven circuit effects.

• Enriched Environment Protects Neurons via Dual Mitophagy

  2026-09-09

  This study identifies an enriched environment as a neuroprotective intervention that activates both PINK1/parkin-dependent and HIF-1α/BNIP3L-dependent mitophagy after cerebral ischemia–reperfusion. Its mechanistic advance is linking dopamine-driven calcium signaling to endogenous H2S production, mitochondrial quality control, oxidative-stress reduction, and improved neurological outcomes.

• JNK-IN-7 Workflow for Apoptosis and JNK Signaling

  2026-09-09

  JNK-IN-7 connects nanomolar JNK target engagement with infection-relevant apoptosis and inflammatory signaling assays. This practical guide shows how to distinguish JNK-dependent c-Jun responses from broader pathway effects in bovine mammary epithelial cells, human IL-1R cells, and RAW264.7 macrophages.

• Cabozantinib (XL184) in RCC Research Workflows

  2026-09-08

  Build reproducible Cabozantinib workflows that separate acute kinase suppression from chronic adaptive signaling in renal cell carcinoma. This guide connects phosphoproteomics, site-specific immunoblotting, motility assays, angiogenesis models, and practical compound handling.

401 records 1/27 page Next 12345 下5页 Last page